Search Results
Search for other papers by Emna Jelloul in
Google Scholar
PubMed
Search for other papers by Georgiana Sitoris in
Google Scholar
PubMed
Search for other papers by Flora Veltri in
Google Scholar
PubMed
Search for other papers by Pierre Kleynen in
Google Scholar
PubMed
Search for other papers by Serge Rozenberg in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
Introduction The guidelines on the management of thyroid disorders in pregnancy (ATA-GL), mention the following: ‘it is important to note that subclinical hyperthyroidism (SH) has not been associated with adverse pregnancy outcomes. Therefore
Search for other papers by Zohar Steinberg Ben-Zeev in
Google Scholar
PubMed
Search for other papers by Marina Peniakov in
Google Scholar
PubMed
Search for other papers by Clari Felszer in
Google Scholar
PubMed
Search for other papers by Scott A Weiner in
Google Scholar
PubMed
Search for other papers by Avishay Lahad in
Google Scholar
PubMed
Search for other papers by Shlomo Almashanu in
Google Scholar
PubMed
The Rappaport Faculty of Medicine, Technion, Institute of Technology, Haifa, Israel
Search for other papers by Yardena Tenenbaum Rakover in
Google Scholar
PubMed
hyperthyroidism and hypothyroidism both affect the fetal and neonatal thyroid. Hyperthyroidism is mainly caused by Graves’ disease, and hypothyroidism during pregnancy in most women is attributed to Hashimoto's thyroiditis. In Graves’ disease, fetal and newborn
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by Heleen I Jansen in
Google Scholar
PubMed
Search for other papers by Antonius E van Herwaarden in
Google Scholar
PubMed
Search for other papers by Henk J Huijgen in
Google Scholar
PubMed
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Rebecca C Painter in
Google Scholar
PubMed
Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by Jacquelien J Hillebrand in
Google Scholar
PubMed
Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
pregnancy, since the fetus does not produce thyroid hormone itself until 16–20 weeks ( 7 ). Untreated maternal hyperthyroidism can not only have fetal consequences such as intra-uterine growth restriction but also life-threatening maternal consequences as
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Search for other papers by Niels Henrik Bruun in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Peter Astrup Christensen in
Google Scholar
PubMed
Search for other papers by Simon Lykkeboe in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Aase Handberg in
Google Scholar
PubMed
Search for other papers by Annebirthe Bo Hansen in
Google Scholar
PubMed
Search for other papers by Maja Hjelm Lundgaard in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Louise Knøsgaard in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Nanna Maria Uldall Torp in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Jesper Karmisholt in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Steno Diabetes Center North Jutland, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Peter Vestergaard in
Google Scholar
PubMed
Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Introduction Hypo- and hyperthyroidism in women of reproductive age are predominantly autoimmune disorders ( 1 , 2 ). Thyroid autoantibodies are key markers of underlying autoimmunity, and thyroid peroxidase antibodies (TPO-Ab) as well as
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Louise Knøsgaard in
Google Scholar
PubMed
Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Search for other papers by Annebirthe Bo Hansen in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Steno Diabetes Center North Jutland, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Peter Vestergaard in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
thyroid function was defined when TSH or fT4 was outside the method- and pregnancy week-specific reference ranges. Biochemical hyperthyroidism or hypothyroidism was then defined by TSH below or above the reference ranges, respectively. Isolated changes in
Search for other papers by Lise Husted in
Google Scholar
PubMed
Search for other papers by Sidsel Rødgaard-Hansen in
Google Scholar
PubMed
Search for other papers by Maja Hjelm Lundgaard in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Nanna Maria Uldall Torp in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
, it is stated as part of the recommendations that disorders of thyroid function may affect levels of CysC ( 5 ) and in particular that hypothyroidism is associated with lower and hyperthyroidism with higher levels of CysC ( 7 ). However, the underlying
Search for other papers by Victor J M Pop in
Google Scholar
PubMed
Search for other papers by Johannes G Krabbe in
Google Scholar
PubMed
Search for other papers by Maarten Broeren in
Google Scholar
PubMed
Search for other papers by Wilmar Wiersinga in
Google Scholar
PubMed
Search for other papers by Margaret P Rayman in
Google Scholar
PubMed
hypothyroidism 11 (0.5) Excluded Overt hyperthyroidism 33 (1.2) 26 (1.1) Sub-clinical hypothyroidism TSH >3.37 and <10 mIU/L 99 (3.6) 81 (3.3) TSH >10 mIU/L 4 (0.1) Excluded Sub-clinical hyperthyroidism
Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
Search for other papers by Hongcheng Wei in
Google Scholar
PubMed
Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
Search for other papers by Quanquan Guan in
Google Scholar
PubMed
Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
Search for other papers by Qiurun Yu in
Google Scholar
PubMed
Search for other papers by Ting Chen in
Google Scholar
PubMed
Search for other papers by Xu Wang in
Google Scholar
PubMed
Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
Search for other papers by Yankai Xia in
Google Scholar
PubMed
information about their gestational age were also excluded. Participants with diagnosed hypothyroidism, subclinical hypothyroidism, hyperthyroidism, subclinical hyperthyroidism and other thyroid diseases ( n = 767), type 1/2 diabetes ( n = 378) and
Search for other papers by Georgiana Sitoris in
Google Scholar
PubMed
Search for other papers by Flora Veltri in
Google Scholar
PubMed
Search for other papers by Pierre Kleynen in
Google Scholar
PubMed
Search for other papers by Malika Ichiche in
Google Scholar
PubMed
Search for other papers by Serge Rozenberg in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
.74 mIU/L and subclinical hyperthyroidism was defined as a serum TSH level <0.06 mIU/L together with a normal FT4 level (10.29–18.02 pmol/L), respectively. Isolated hypothyroxinaemia (IH) was defined as an FT4 level <2.5th percentile (10.29 pmol/L) with
Search for other papers by Georgiana Sitoris in
Google Scholar
PubMed
Search for other papers by Flora Veltri in
Google Scholar
PubMed
Search for other papers by Malika Ichiche in
Google Scholar
PubMed
Search for other papers by Pierre Kleynen in
Google Scholar
PubMed
Search for other papers by Jean-Philippe Praet in
Google Scholar
PubMed
Search for other papers by Serge Rozenberg in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
OR 1.65 (95% CI, 1.13–2.40) ( 28 ). Concerning women with subclinical hyperthyroidism (à priori due to the high hCG levels), they might have normalized their TSH levels later in pregnancy, which cannot be confirmed due to the absence of repeated